Search Videos and More
Showing 1 - 12 of 12 results
Course
Complex Patient Case Review for Oncologic and Benign Urology
Live Webinar | 5:00 PM - 6:00 PM EDT | Wednesday, May 21, 2025
News
Temple Lung Center: Advances in Lung Care and Research in 2024
The Temple Lung Center continued to set the standard in lung health throughout 2024, delivering exceptional clinical care and advancing lung disease research. Through expanded screening programs and innovative clinical trials, our multidisciplinary team—including pulmonologists, thoracic surgeons, and other specialists—provided patients with breakthrough options for diagnosing and treating even the most complex lung conditions.
Video
What is new in 2024 for PE
A comprehensive overview of strategic clinical risk stratification, evidence-based approaches derived from clinical trials and advanced research, and essential insights into the follow-up care of patients post-pulmonary embolism (PE).
News
Lung Transplant Program Referral Information
The Temple Lung Transplant Program is a leader in both quantity and quality. It’s the nation’s highest volume program, but it also has the best one-year survival rates in Philadelphia and all of Pennsylvania.
News
Referral Protocol for Pulmonary Hypertension, Right Heart Failure, and CTEPH Program at Temple
When it comes to identifying and treating the complex causes of pulmonary hypertension and its and affiliated conditions, the Temple Heart & Vascular Institute is the clear choice for your patients.
Course
COVID Pneumonia
"COVID pneumonia represents the active inflammation of the pulmonary parenchyma that is caused by SARS-CoV-2, the coronavirus that has caused the COVID-19 pandemic. Millions of patients have been affected worldwide and hospitalizations have occurred all over the globe. The condition can range from mild to severe and represents a challenge for clinicians. Despite the above there is still significant morbidity and mortality associated with COVID pneumonia. It is important for clinicians to recognize this entity, and follow closely the rapidly changing recommendations regarding management and treatment."
Document
Advanced Asthma Fact Sheet
While many cases of asthma can be managed in a primary care setting, 5–10% of patients have asthma that cannot be controlled by standard treatments.
News
Tracheobronchial Malacia Referral Information
The Tracheobronchomalacia (TBM) Program at the Temple Lung Center offers patients with this rare and often under-recognized condition, a multidisciplinary medical team led by specialty-trained thoracic surgeon Charles Bakhos, MD, FACS.
News
Humidified Nasal High-Flow Therapy May Be an Effective At-Home Treatment for COPD
A pilot study at Temple suggests that daily use of humidified nasal high-flow (NHF) therapy with an air-oxygen blend as a maintenance therapy could benefit patients discharged from hospital after an acute exacerbation of COPD.
News
New Treatment Pathways for Persistent Pulmonary Hypertension of the Newborn
Persistent pulmonary hypertension of the newborn (PPHN, also known as neonatal pulmonary hypertension and persistent fetal circulation syndrome), affects 2% of live births and is a major cause of neonatal mortality.
Course
Standardizing the Pulmonary Embolism care with Pulmonary Embolism Response Teams (PERT)
This activity is intended for medical professionals who have a clinical interest in the management of pulmonary embolisms as seen by the following medical specialists: Pulmonologists, Hospitalists, Intensivists, Primary Care Providers, Internists, Physician Assistants, and Nurse Practitioners.
Course
High-Yield Updates in ILD
This activity will inform physicians and advanced practice providers about the rapidly-advancing field of interstitial lung diseases (ILDs), which encompasses many elements important to the care of an ILD patient, including accurate diagnosis, complications and comorbidities, treatment options, research opportunities, and transplantation evaluation.